Phathom Pharmaceuticals (PHAT) Stock Chart & Stock Price History → Your $200 account credit is about to expire (From MarketBeat) (Ad) Free PHAT Stock Alerts $10.54 -0.15 (-1.40%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Phathom Pharmaceuticals Stock Price Performance5 Day Performance+1.44%1 Month Performance+17.50%3 Month Performance+13.46%6 Month Performance+40.53%Year-To-Date Performance+15.44%1 Year Performance-20.39% Receive PHAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phathom Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. PHAT Stock Chart for Sunday, May, 19, 2024 PHAT Chart by TradingView Phathom Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$10.69$10.54-1.40%$10.77$10.25533,940 shs$616.91 million05/16/2024$10.41$10.69+2.69%$10.75$10.31336,040 shs$625.74 million05/15/2024$10.39$10.41+0.19%$10.68$10.10334,255 shs$609.35 million05/14/2024$9.67$10.39+7.45%$10.62$9.70536,410 shs$608.13 million05/13/2024$9.53$9.67+1.52%$10.00$9.39600,598 shs$565.99 million05/10/2024$10.09$9.53-5.60%$10.56$9.34855,931 shs$557.44 million Get the Latest News and Ratings for PHAT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Phathom Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$10.10$10.09-0.10%$11.15$9.681.11 million shs$590.47 million05/08/2024$10.24$10.10-1.37%$10.49$9.87537,546 shs$591.05 million05/07/2024$10.84$10.24-5.54%$11.02$10.16533,379 shs$599.25 million05/06/2024$10.04$10.84+7.97%$11.24$10.08697,668 shs$634.36 million05/03/2024$9.76$10.04+2.87%$10.37$9.84647,291 shs$587.54 million05/02/2024$9.26$9.76+5.40%$9.85$9.361.07 million shs$571.16 million05/01/2024$9.03$9.26+2.55%$9.54$8.96512,282 shs$541.90 million04/30/2024$9.35$9.03-3.42%$9.33$8.99413,591 shs$528.47 million04/29/2024$9.18$9.35+1.85%$9.49$8.95430,906 shs$547.16 million04/26/2024$9.10$9.18+0.88%$9.43$8.96370,886 shs$537.21 million04/25/2024$9.12$9.10-0.22%$9.36$8.74542,899 shs$532.53 million04/24/2024$9.06$9.12+0.66%$9.32$9.04440,208 shs$533.70 million04/23/2024$9.01$9.06+0.55%$9.29$8.92582,126 shs$530.19 million04/22/2024$8.97$9.01+0.45%$9.18$8.83475,101 shs$527.27 million04/19/2024$9.48$8.97-5.38%$9.88$8.91590,192 shs$524.92 million04/18/2024$9.80$9.48-3.27%$9.82$9.45421,170 shs$554.77 million04/17/2024$10.03$9.80-2.29%$10.30$9.70426,169 shs$573.50 million04/16/2024$10.02$10.03+0.10%$10.28$9.88613,336 shs$586.52 million04/15/2024$10.14$10.02-1.18%$10.31$9.68597,330 shs$585.97 million04/12/2024$10.47$10.14-3.15%$11.20$9.97949,517 shs$592.99 million04/11/2024$11.80$10.47-11.27%$12.09$10.281.05 million shs$612.25 million04/10/2024$12.05$11.80-2.07%$12.05$11.241.44 million shs$690.06 million04/09/2024$11.11$12.05+8.46%$12.25$10.981.27 million shs$704.68 million04/08/2024$11.03$11.11+0.73%$11.30$10.88701,587 shs$649.71 million04/05/2024$10.80$11.03+2.13%$11.07$10.411.51 million shs$645.03 million04/04/2024$9.86$10.80+9.53%$10.80$9.86946,366 shs$631.58 million04/03/2024$9.80$9.86+0.61%$10.00$9.57451,617 shs$576.61 million04/02/2024$10.60$9.80-7.55%$10.40$9.55767,605 shs$573.10 million04/01/2024$10.62$10.60-0.19%$11.11$10.49729,084 shs$619.89 million03/29/2024$10.62$10.62$11.22$10.42886,416 shs$621.06 million03/28/2024$11.05$10.62-3.89%$11.22$10.42886,406 shs$621.06 million03/27/2024$10.50$11.05+5.24%$11.14$10.21751,089 shs$646.20 million03/26/2024$10.45$10.50+0.48%$11.41$10.431.09 million shs$614.04 million03/25/2024$11.02$10.45-5.17%$11.36$10.211.17 million shs$611.12 millionHow this is some devastating news (Ad)Check out this report real quick… It’s full proof that most people barely have enough money to cover the monthly expenditures… Let alone save for retirement or plan the next vacation. At the risk of sounding political… If you’re waiting for the Fed, or the government or some financial advisor to come to change things for the better… You might be waiting for a long long time. But what if…? What if there was a way to completely turn the tables?But I can promise that you’ll see all the details for yourself here.03/22/2024$9.16$11.02+20.31%$11.40$9.111.52 million shs$644.45 million03/21/2024$9.12$9.16+0.44%$9.86$9.10481,476 shs$535.68 million03/20/2024$8.62$9.12+5.80%$9.19$8.53592,733 shs$533.34 million03/19/2024$8.28$8.62+4.11%$8.81$8.18483,271 shs$504.10 million03/18/2024$8.49$8.28-2.47%$8.68$8.12556,804 shs$484.21 million03/15/2024$7.77$8.49+9.27%$8.51$7.83967,135 shs$496.50 million03/14/2024$8.00$7.77-2.88%$8.00$7.55554,230 shs$454.39 million03/13/2024$8.17$8.00-2.08%$8.35$7.98504,727 shs$467.84 million03/12/2024$8.26$8.17-1.09%$8.62$7.87721,623 shs$477.76 million03/11/2024$8.88$8.26-6.98%$9.15$8.21698,970 shs$483.05 million03/08/2024$9.09$8.88-2.31%$9.38$8.57790,342 shs$508.38 million03/07/2024$9.73$9.09-6.58%$10.56$8.571.34 million shs$520.40 million03/06/2024$9.93$9.73-2.01%$9.96$9.21593,324 shs$557.04 million03/05/2024$10.29$9.93-3.50%$10.37$9.90974,991 shs$568.49 million03/04/2024$10.69$10.29-3.74%$10.87$10.21586,643 shs$589.10 million03/01/2024$10.70$10.69-0.09%$10.90$10.511.01 million shs$612.00 million02/29/2024$10.78$10.70-0.74%$11.16$10.38977,587 shs$612.58 million02/28/2024$10.15$10.78+6.21%$11.18$9.802.12 million shs$617.16 million02/27/2024$9.91$10.15+2.42%$10.27$9.851.11 million shs$581.12 million02/26/2024$10.60$9.91-6.51%$10.81$9.90627,575 shs$567.35 million02/23/2024$10.47$10.60+1.24%$11.43$9.971.14 million shs$606.85 million02/22/2024$10.21$10.47+2.55%$10.94$9.841.11 million shs$599.41 million02/21/2024$10.17$10.21+0.39%$10.47$9.631.01 million shs$584.52 million02/20/2024$9.29$10.17+9.47%$10.83$9.301.84 million shs$582.23 million02/19/2024$9.29$9.29$10.93$6.815.23 million shs$531.85 million Related Companies: ORIC Pharmaceuticals Stock Price Chart Stoke Therapeutics Stock Price Chart ArriVent BioPharma Stock Price Chart Avid Bioservices Stock Price Chart Silence Therapeutics Stock Price Chart Savara Stock Price Chart Zymeworks Stock Price Chart Harrow Stock Price Chart Olema Pharmaceuticals Stock Price Chart Lyell Immunopharma Stock Price Chart Receive PHAT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Phathom Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PHAT) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phathom Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.